Childhood Kidney Diseases

Korean Society of Pediatric Nephrology (대한소아신장학회)
권호 표지
DOI QR코드

DOI QR Code

Mitogen-activated Protein Kinases in the Development of Normal and Diseased Kidneys

  • Awazu, Midori (Department of Pediatrics, Keio University School of Medicine)
  • Received : 2017.02.03
  • Accepted : 2017.03.06
  • Published : 2017.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Mitogen-activated protein kinases (MAPKs) play important roles in various cellular functions including proliferation, differentiation, and apoptosis. We showed that MAPKs are developmentally regulated in the rat kidney. p38 MAPK (p38) and extracellular signal-regulated kinase (ERK) were strongly expressed in the fetal kidney, whereas c-Jun N-terminal kinase (JNK) was detected predominantly in the adult kidney. The inhibition of p38 or ERK in organ culture resulted in reduced nephron formation with or without reduced kidney size. On the other hand, persistent fetal expression pattern of MAPKs, i.e., upregulation of p38 and ERK and downregulation of JNK, was observed in the cyst epithelium of human renal dysplasia, ovine fetal obstructive uropathy, and pcy mice, a model of polycystic kidney disease. Furthermore, activated p38 and ERK induced by cyclic stretch mediated proliferation and $TGF-{\beta}1$ expression in ureteric bud cells, probably leading to cyst formation and dysplastic changes. Inhibition of ERK slowed the disease progression in pcy mice. Finally, ERK and p38 were inactivated in the early embryonic kidney subjected to maternal nutrient restriction, characterized by reduced ureteric branching and nephron number. Thus, MAPKs mediate the development of normal and diseased kidney. Their modulation may result in novel therapeutic strategies against developmental abnormalities of the kidney.

Keywords

References

  1. Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999;19:2435-44. https://doi.org/10.1128/MCB.19.4.2435
  2. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-31. https://doi.org/10.1126/science.270.5240.1326
  3. Omori S, Hida M, Ishikura K, Kuramochi S, Awazu M. Expression of mitogen-activated protein kinase family in rat renal development. Kidney Int 2000;58:27-37. https://doi.org/10.1046/j.1523-1755.2000.00137.x
  4. Hida M, Omori S, Awazu M. ERK and p38 MAP kinase are required for rat renal development. Kidney Int 2002;61:1252-62. https://doi.org/10.1046/j.1523-1755.2002.00273.x
  5. Omori S, Hida M, Fujita H, Takahashi H, Tanimura S, Kohno M, et al. Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease. J Am Soc Nephrol 2006;17:1604-14. https://doi.org/10.1681/ASN.2004090800
  6. Omori S, Fukuzawa R, Hida M, Awazu M. Expression of mitogenactivated protein kinases in human renal dysplasia. Kidney Int 2002;61:899-906. https://doi.org/10.1046/j.1523-1755.2002.00196.x
  7. Omori S, Kitagawa H, Koike J, Fujita H, Hida M, Pringle KC, et al. Activated extracellular signal-regulated kinase correlates with cyst formation and transforming growth factor-beta expression in fetal obstructive uropathy. Kidney Int 2008;73:1031-7. https://doi.org/10.1038/ki.2008.3
  8. Fisher CE, Michael L, Barnett MW, Davies JA. Erk MAP kinase regulates branching morphogenesis in the developing mouse kidney. Development 2001;128:4329-38.
  9. Ihermann-Hella A, Lume M, Miinalainen IJ, Pirttiniemi A, Gui Y, Peranen J, et al. Mitogen-activated protein kinase (MAPK) pathway regulates branching by remodeling epithelial cell adhesion. PLoS Genet 2014;10:e1004193. https://doi.org/10.1371/journal.pgen.1004193
  10. Smeeton J, Dhir P, Hu D, Feeney MM, Chen L, Rosenblum ND. Integrin-linked kinase controls renal branching morphogenesis via dual specificity phosphatase 8. J Am Soc Nephrol 2016;27:1465-77. https://doi.org/10.1681/ASN.2015020139
  11. Osafune K, Takasato M, Kispert A, Asashima M, Nishinakamura R. Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay. Development 2006;133:151-61. https://doi.org/10.1242/dev.02174
  12. Blank U, Brown A, Adams DC, Karolak MJ, Oxburgh L. BMP7 promotes proliferation of nephron progenitor cells via a JNK-dependent mechanism. Development 2009;136:3557-66. https://doi.org/10.1242/dev.036335
  13. Peters CA. Obstruction of the fetal urinary tract. J Am Soc Nephrol 1997;8:653-63.
  14. Winyard PJ, Risdon RA, Sams VR, Dressler GR, Woolf AS. The PAX2 tanscription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. J Clin Invest 1996;98:451-9. https://doi.org/10.1172/JCI118811
  15. Kitagawa H, Pringle KC, Koike J, Nagae H, Zuccollo J, Sato Y, et al. Early bladder wall changes after creation of obstructive uropathy in the fetal lamb. Pediatr Surg Int 2006;22:875-9. https://doi.org/10.1007/s00383-006-1755-z
  16. Fujita H, Hida M, Kanemoto K, Fukuda K, Nagata M, Awazu M. Cyclic stretch induces proliferation and TGF-${\beta}1$-mediated apoptosis via p38 and ERK in ureteric bud cells. Am J Physiol Renal Physiol 2010;299:F648-55. https://doi.org/10.1152/ajprenal.00402.2009
  17. Olbrich H, Fliegauf M, Hoefele J, Kispert A, Otto E, Volz A, et al. Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis. Nat Genet 2003;34:455-9. https://doi.org/10.1038/ng1216
  18. Ohashi R, Nakagawa T, Watanabe S, Kanellis J, Almirez RG, Schreiner GF, et al. Inhibition of p38 mitogen-activated protein kinase augments progression of remnant kidney model by activating the ERK pathway. Am J Pathol 2004;164:477-85. https://doi.org/10.1016/S0002-9440(10)63138-0
  19. Awazu M, Hida M. Maternal nutrient restriction inhibits ureteric bud branching but does not affect the duration of nephrogenesis in rats. Pediatr Res 2015;77:633-9. https://doi.org/10.1038/pr.2015.24
  20. Henry TQ, Mansano RZ, Nast CC, Lakshmanan J, Abdallah M, Abdel-Hakeem AK, et al. GDNF and MAPK-ERK pathway signaling is reduced during nephrogenesis following maternal undernutrition. J Dev Orig Health Dis 2010;1:67-74. https://doi.org/10.1017/S2040174409990134
  21. Pozzi A, Coffa S, Bulus N, Zhu W, Chen D, Chen X, et al. H-Ras, RRas, and TC21 differentially regulate ureteric bud cell branching morphogenesis. Mol Biol Cell 2006;17:2046-56. https://doi.org/10.1091/mbc.e05-08-0800
  22. Usui J, Yamada R, Kanemoto K, Koyama A, Nagata M. Murine metanephric mesenchyme possesses characteristics of vascular endothelial cells in vitro. Nephron Exp Nephrol 2006;102:e93-8.
  23. Piscione TD, Phan T, Rosenblum ND. BMP7 controls collecting tubule cell proliferation and apoptosis via Smad1-dependent and -independent pathways. Am J Physiol Renal Physiol 2001;280:F19-33. https://doi.org/10.1152/ajprenal.2001.280.1.F19
  24. Kazama I, Mahoney Z, Miner JH, Graf D, Economides AN, Kreidberg JA. Podocyte-derived BMP7 is critical for nephron development. J Am Soc Nephrol 2008;19:2181-91. https://doi.org/10.1681/ASN.2007111212
  25. Awazu M, Ishikura K, Hida M, Hoshiya M. Mechanisms of mitogenactivated protein kinase activation in experimental diabetes. J Am Soc Nephrol 1999;10:738-45.
  26. Fujita H, Omori S, Ishikura K, Hida M, Awazu M. ERK and p38 mediate high-glucose-induced hypertrophy and TGF-${\beta}$ expression in renal tubular cells. Am J Physiol Renal Physiol 2004;286: F120-6. https://doi.org/10.1152/ajprenal.00351.2002
  27. Feliers D, Kasinath BS. Erk in kidney diseases. J Signal Transduct 2011;768512.
  28. Stambe C, Atkins RC, Tesch GH, Masaki T, Schreiner GF, Nikolic-Paterson DJ. The role of $p38{\alpha}$ mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol 2004;15:370-9. https://doi.org/10.1097/01.ASN.0000109669.23650.56
  29. Furuichi K, Wada T, Iwata Y, Sakai N, Yoshimoto K, Kobayashi Ki K, et al. Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice. Nephrol Dial Transplant 2002;17:399-407. https://doi.org/10.1093/ndt/17.3.399
  30. Ozaki KI, Awazu M, Tamiya M, Iwasaki Y, Harada A, Kugisaki S, et al. Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes. Am J Physiol Endocrinol Metab 2016;310:E643-E51. https://doi.org/10.1152/ajpendo.00445.2015
  31. Nutter FH, Haylor JL, Khwaja A. Inhibiting ERK Activation with CI-1040 Leads to Compensatory Upregulation of Alternate MAPKs and Plasminogen Activator Inhibitor-1 following Subtotal Nephrectomy with No Impact on Kidney Fibrosis. PLoS One 2015; 10:e0137321. https://doi.org/10.1371/journal.pone.0137321